Definitive Contract 75F40124C00128

Award Date 9/25/24
Potential Completion Date 4/4/25
Potential Value $978K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02114, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a renowned nonprofit academic medical center in Boston, Massachusetts. The contract, valued at $594,105.87, is for the "RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - COORDINATION CENTER" and is a delivery order with a firm fixed-price pricing type. The funding federal agency is the National Institute of Biomedical Imaging and Bioengineering, a civilian agency....
This is a $263,466 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for research and development of serum samples. The award has no set-aside designation and is scheduled for completion by December 24, 2024. MGH is a renowned non-profit academic medical center and a major recipient of federal research funding, leveraging its extensive facilities and...
This is a firm fixed-price contract award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), by the Defense Advanced Research Projects Agency (DARPA). The $598,436.00 contract is for DARPA Commercial Accelerators Support services, and is a call against a larger Blanket Purchase Agreement (BPA) contract vehicle with a $25,000,000.00 ceiling value that runs through August 2027. The contract is not set aside for any specific business type. MGH is a renowned...
This federal contract award was issued by the Consumer Product Safety Commission to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit 999-bed medical center affiliated with Harvard Medical School. The $185,028.51 firm fixed price purchase order is for data collection on consumer product related injuries. The contract has no set-aside designation and is scheduled for completion by June 30, 2024. MGH has experience as both a prime contractor and...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Advanced Research Projects Agency (DARPA) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The contract, valued at $249,493.00, will provide research program support services to DARPA. MGH is a renowned nonprofit academic medical center located in Boston, Massachusetts, and the primary teaching hospital of Harvard Medical School. The contract is not set aside for...
This is a federal contract award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for a task order under the RAPIDLY-ACTING TREATMENTS FOR TREATMENT-RESISTANT DEPRESSION (RAPID) program administered by the National Institute on Drug Abuse (NIDA). The $110,977 fixed-price task order has an ultimate completion date of September 14, 2016. MGH is a non-profit, 999-bed medical center that conducts extensive biomedical research, including clinical trials and...
This is a firm fixed-price contract award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), by the Defense Advanced Research Projects Agency (DARPA) for research program support services. The contract has a ceiling value of $590,936 and a completion date of December 8, 2026. The award is not set aside for any specific business type, indicating MGH's competitiveness across federal research markets. MGH is a renowned nonprofit academic medical center that...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $8,878,380.66 Firm Fixed Price delivery order contract to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to establish an NIBIB Innovation Funnel Coordination Center for the RadX Innovation Funnel for COVID-19. This contract supports research, clinical, and technical services related to the development of medical countermeasures against COVID-19. MGH is a 999-bed medical...
This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The $146,490.94 contract is for the RADX Independent Test Assessment Program for Hepatitis C Virus - Coordination Center. The purpose of this modification is to update the program acronym to read RADX. The contract has an...
This is a federal contract award to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for DARPA Research Program Support Services. The contract is a Blanket Purchase Agreement (BPA) Call with a ceiling value of $588,436.00 and a completion date of December 7, 2026. The contract is not set aside for any specific business type, indicating MGH's competitive positioning in federal research markets. Under this BPA, MGH has already received two firm...

This is a $978,324 definitive contract awarded by the Food and Drug Administration (FDA) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for a 2-year period ending in April 2025. The contract is to enhance the FDA's Source Model by incorporating and analyzing state and regional-level data.

The contract was awarded under a Broad Agency Announcement (BAA) that solicits advanced research and development proposals to support FDA regulatory science priorities. The BAA does not have a set-aside designation. As a major academic medical center and research institution, MGH has extensive experience conducting biomedical research and providing specialized services through federal contracts and grants from agencies like the NIH, DoD, and CDC. The contract work is expected to leverage MGH's expertise and specialized facilities to support the FDA's regulatory science mission.

Generated 4/6/25, 12:50 AM